Evaluation of Novel Stereotactic Cannula for Stem Cell Transplantation against Central Nervous System Disease
Cell therapy for central nervous system (CNS) disorders is beginning to prove its safety and efficiency. Intraparenchymal transplantation can be an option for cell delivery; however, one concern regarding this method is that the transplantation cannula may cause additional brain injuries. These incl...
Saved in:
Main Authors: | Masahito Kawabori (Author), Aki Tanimori (Author), Shinri Kitta (Author), Hideo Shichinohe (Author), Kiyohiro Houkin (Author) |
---|---|
Format: | Book |
Published: |
Hindawi Limited,
2020-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Corrigendum to "Evaluation of Novel Stereotactic Cannula for Stem Cell Transplantation against Central Nervous System Disease"
by: Masahito Kawabori, et al.
Published: (2021) -
Intracerebral Transplantation of Mesenchymal Stromal Cell Compounded with Recombinant Peptide Scaffold against Chronic Intracerebral Hemorrhage Model
by: Soichiro Takamiya, et al.
Published: (2022) -
Human Recombinant Peptide Sponge Enables Novel, Less Invasive Cell Therapy for Ischemic Stroke
by: Michiyuki Miyamoto, et al.
Published: (2018) -
Mesenchymal Stem Cell Sheet Promotes Functional Recovery and Palliates Neuropathic Pain in a Subacute Spinal Cord Injury Model
by: Kazuyoshi Yamazaki, et al.
Published: (2021) -
Feasibility and Efficiency of Human Bone Marrow Stromal Cell Culture with Allogeneic Platelet Lysate-Supplementation for Cell Therapy against Stroke
by: Chengbo Tan, et al.
Published: (2016)